CrossrefInfokarte
Effectiveness and safety of romosozumab followed by 2 years of sequential therapy with denosumab in a real-world setting to investigate the influence of prior treatments
The Journal of Medical Investigation · 2026 · 73 (3.4) · 425-433
DOI: 10.2152/jmi.73.425 ↗Abstract
Kein Abstract verfügbar.
EUVIMED